PIAS3 and colorectal cancer: Recently, it was demonstrated that CASC2 in colorectal cancer is functioning as ceRNA for miR-18a, thereby modulating the expression of target gene PIAS3, and subsequently inhibiting CRC cell proliferation and tumor growth [14].